Immunisation with gp160 in HIV-1 infection

被引：0
|
作者：
Flala, C
Stewart, GT
机构：
[1] Glenavon, Bristol BS8 3HT, Avon, England
[2] Krankenhaus Korneuburg, A-2100 Korneuburg, Austria
[3] Univ Glasgow, Dept Publ Hlth, Glasgow, Lanark, Scotland
来源：
LANCET | 1999年 / 354卷 / 9182期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：948 / 948
页数：1
相关论文
共 50 条
  • [31] Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type I (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp160 of HIV-1 and boosted with a recombinant gp160
    Fleury, B
    Janvier, G
    Pialoux, G
    Buseyne, F
    Robertson, MN
    Tartaglia, J
    Paoletti, E
    Kieny, MP
    Excler, JL
    Riviere, Y
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04): : 734 - 738
  • [32] FUNCTIONAL ROLES OF THE V3 HYPERVARIABLE REGION OF HIV-1 GP160 IN THE PROCESSING OF GP160 AND IN THE FORMATION OF SYNCYTIA IN CD4+ CELLS
    TRAVIS, BM
    DYKERS, TI
    HEWGILL, D
    LEDBETTER, J
    TSU, TT
    HU, SL
    LEWIS, JB
    VIROLOGY, 1992, 186 (01) : 313 - 317
  • [33] Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gp160 vaccine among adults with advanced HIV infection
    DeMaria, A
    Kunches, L
    Mayer, K
    Cohen, C
    Epstein, P
    Werner, B
    Day, J
    DeCristofaro, J
    Landers, S
    Tang, Y
    Coady, W
    JOURNAL OF HUMAN VIROLOGY, 2000, 3 (04) : 182 - 192
  • [34] Prediction of VRC01 Neutralization Sensitivity by HIV-1 gp160 Sequence Features
    Magaret, Craig A.
    Williamson, Brian D.
    Borate, Bhavesh
    Carpp, Lindsay
    Georgiev, Ivelin
    Setliff, Ian
    Dingens, Adam S.
    Benkesser, David C.
    Simon, Noah
    Carone, Marco
    Montefiori, David
    Alter, Galit
    Yu, Wen-Han
    Juraska, Michal
    Edlefsen, Paul T.
    Karuna, Shelly
    Mgodi, Nyaradzo M.
    Edugupanti, Srilatha
    Gilbert, Peter B.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 344 - 344
  • [35] Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis
    Micoli, KJ
    Pan, G
    Wu, Y
    Williams, JP
    Cook, WJ
    McDonald, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) : 1233 - 1240
  • [36] HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) GP160-SPECIFIC LYMPHOCYTE PROLIFERATIVE RESPONSES OF MONONUCLEAR LEUKOCYTES FROM HIV-1 RECOMBINANT GP160 VACCINE RECIPIENTS
    KEEFER, MC
    BONNEZ, W
    ROBERTS, NJ
    DOLIN, R
    REICHMAN, RC
    JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03): : 448 - 453
  • [37] Illustrating the correlations between protein dynamics and glycan shielding of HIV-1 Env gp160
    Suresh, Raghavendran
    Mani, Natesan
    Chakraborty, Srirupa
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 189A - 189A
  • [38] Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features
    Magaret, Craig A.
    Benkeser, David C.
    Williamson, Brian D.
    Borate, Bhavesh R.
    Carpp, Lindsay N.
    Georgiev, Ivelin S.
    Setliff, Ian
    Dingens, Adam S.
    Simon, Noah
    Carone, Marco
    Simpkins, Christopher
    Montefiori, David
    Alter, Galit
    Yu, Wen-Han
    Juraska, Michal
    Edlefsen, Paul T.
    Karuna, Shelly
    Mgodi, Nyaradzo M.
    Edugupanti, Srilatha
    Gilbert, Peter B.
    PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (04) : 1 - 35
  • [39] ENVELOPE-SPECIFIC ANTIBODIES IN THE SALIVA OF INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-1 GP160
    VASUDEVACHARI, MB
    UFFELMAN, KW
    KOVACS, J
    YEH, CK
    LANE, HC
    SALZMAN, NP
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1992, 5 (08): : 817 - 821
  • [40] Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn)
    Guerra, E
    Ricci, G
    Carlesimo, M
    Varani, AR
    Pontesilli, O
    Scala, E
    Mezzaroma, I
    Pierdominici, M
    Pandolfi, F
    Antinori, A
    DeLuca, A
    Murri, R
    Ammassari, A
    Ortona, L
    Aiuti, F
    DEVELOPMENT AND APPLICATIONS OF VACCINES AND GENE THERAPY IN AIDS, 1996, 48 : 147 - 154
12345